G. Stoppe et al., FACTORS INFLUENCING THE PRESCRIBING OF ]] NOOTROPIC[[ MEDICATIONS - RESULTS OF A REPRESENTATIVE INQUIRY IN LOWER SAXONY, Deutsche Medizinische Wochenschrift, 120(47), 1995, pp. 1614-1619
Aim of investigation: To discover (1) to what extent patients' wishes
and the extent of any abnormality of brain performance influence the f
requency with which >>nootropic<< drugs (those thought to affect brain
activity, e.g. piracetam, pyritinol, or improve cerebral circulation,
e.g. xanthine derivatives, Ginkgo biloba, secale alkaloids, calcium a
ntagonists) are prescribed; (2) the medical. practitioner's expectatio
ns of the effectiveness of such medications. Method: In a personal int
erview, 145 family doctors and 14 neurologists in private practice in
the Gottingen area of Germany (participation rate: 83.2% of those aske
d to participate) were questioned about fictitious cases (case 1: mild
memory problem with or without expressed wish for medication; case 2:
moderate dementia, of Alzheimer or multi-infarct type). The previousl
y arranged interviews, which took place in the doctors' practice rooms
, consisted of standardized open questions to the written case reports
. Results: Regardless of the wish of the patient and the extent and ty
pe of the abnormal brain function at-tout 70% of all participating doc
tors would prescribe those drugs, even though about 56% had doubts abo
ut their effectiveness. About 28% expected a positive effect on brain
performance. A nearly equal proportion of doctors would continue an ex
isting drug regimen as would prescribe one. Conclusion: The prescripti
on of the named group of drugs is influenced less by medical criteria
than by factors which concern doctor-patient relationship.